Selected article for: "activation secretion and lung injury"
Author: Scheraga, Rachel G.; Southern, Brian D.; Grove, Lisa M.; Olman, Mitchell A.
Title: The Role of TRPV4 in Regulating Innate Immune Cell Function in Lung Inflammation
  • Cord-id: euatl32q
  • Document date: 2020_6_26
    • ID: euatl32q
    Snippet: Ion channels/pumps are essential regulators of innate immune cell function. Macrophages have been increasingly recognized to have phenotypic plasticity and location-specific functions in the lung. Transient receptor potential vanilloid 4 (TRPV4) function in lung injury has been shown to be stimulus- and cell-type specific. In the current review, we discuss the importance of TRPV4 in macrophages and its role in phagocytosis and cytokine secretion in acute lung injury/acute respiratory distress sy
    Document: Ion channels/pumps are essential regulators of innate immune cell function. Macrophages have been increasingly recognized to have phenotypic plasticity and location-specific functions in the lung. Transient receptor potential vanilloid 4 (TRPV4) function in lung injury has been shown to be stimulus- and cell-type specific. In the current review, we discuss the importance of TRPV4 in macrophages and its role in phagocytosis and cytokine secretion in acute lung injury/acute respiratory distress syndrome (ARDS). Furthermore, TRPV4 controls a MAPK molecular switch from predominately c-Jun N-terminal kinase, JNK activation, to that of p38 activation, that mediates phagocytosis and cytokine secretion in a matrix stiffness-dependent manner. Expanding knowledge regarding the downstream mechanisms by which TRPV4 acts to tailor macrophage function in pulmonary inflammatory diseases will allow for formulation of novel therapeutics.

    Search related documents:
    Co phrase search for related documents
    • activate pathway and lung injury: 1, 2, 3
    • activate pathway and lung injury activate: 1, 2
    • activate pathway and lung injury ameliorate: 1, 2
    • activation immune cell function and lung injury: 1
    • active area and lung injury: 1
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung injury activate: 1, 2, 3
    • acute lung injury and lung injury ameliorate: 1, 2, 3, 4, 5, 6, 7, 8
    • acute lung injury and lung injury effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury macrophage and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute lung injury macrophage role and lung injury: 1
    • acute lung injury pathogenesis and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lps active and lung injury: 1
    • lps bleomycin and lung injury: 1, 2, 3, 4
    • lps induce and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • lps intratracheal instillation and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lps intratracheal instillation and lung injury effect: 1
    • lps response and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lps response and lung injury effect: 1